» Articles » PMID: 25885896

Detection and Serotyping of Pneumococci in Community Acquired Pneumonia Patients Without Culture Using Blood and Urine Samples

Overview
Journal BMC Infect Dis
Publisher Biomed Central
Date 2015 Apr 18
PMID 25885896
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Treatment of community acquired pneumonia (CAP) patients with antibiotics before laboratory-confirmed diagnosis leads to loss of knowledge on the causative bacterial pathogen. Therefore, an increasing number of pneumococcal infections is identified using non-culture based techniques. However, methods for serotyping directly on the clinical specimen remain scarce. Here we present three approaches for detection and serotyping of pneumococci using samples from patients with CAP.

Methods: The first approach is quantitative PCR (qPCR) analysis on blood samples (n = 211) followed by capsular sequence typing (CST) to identify the serotype. The second approach, a urinary antigen assay (n = 223), designated as inhibition multiplex immunoassay (IMIA), is based on Luminex technology targeting 14 serotypes. The third approach is a multiplex immunoassay (MIA) (n = 171) also based on Luminex technology which detects serologic antibody responses against 14 serotypes. The three alternative assays were performed on samples obtained from 309 adult hospitalized CAP patients in 2007-2010 and the results were compared with those obtained from conventional laboratory methods to detect pneumococcal CAP, i.e. blood cultures, sputum cultures and BinaxNOW urinary antigen tests.

Results: Using qPCR, MIA and IMIA, we were able to detect the pneumococcus in samples of 56% more patients compared to conventional methods. Furthermore, we were able to assign a serotype to the infecting pneumococcus from samples of 25% of all CAP patients, using any of the three serotyping methods (CST, IMIA and MIA).

Conclusion: This study indicates the usefulness of additional molecular methods to conventional laboratory methods for the detection of pneumococcal pneumonia. Direct detection and subsequent serotyping on clinical samples will improve the accuracy of pneumococcal surveillance to monitor vaccine effectiveness.

Citing Articles

Electrochemical Detection for Isothermal Loop-Mediated Amplification of Pneumolysin Gene of Based on the Oxidation of Phenol Red Indicator.

Gonzalez-Lopez A, Cima-Cabal M, Rioboo-Legaspi P, Costa-Rama E, Del Mar Garcia-Suarez M, Fernandez-Abedul M Anal Chem. 2022; 94(38):13061-13067.

PMID: 36106671 PMC: 9523611. DOI: 10.1021/acs.analchem.2c02127.


The drop in reported invasive pneumococcal disease among adults during the first COVID-19 wave in the Netherlands explained.

Dirkx K, Mulder B, Post A, Rutten M, Swanink C, Wertheim H Int J Infect Dis. 2021; 111:196-203.

PMID: 34455081 PMC: 8444629. DOI: 10.1016/j.ijid.2021.08.060.


Non-lytic antibiotic treatment in community-acquired pneumococcal pneumonia does not attenuate inflammation: the PRISTINE trial.

Groeneveld G, van der Reyden T, Joosten S, Bootsma H, Cobbaert C, de Vries J J Antimicrob Chemother. 2019; 74(8):2385-2393.

PMID: 31106377 PMC: 6640306. DOI: 10.1093/jac/dkz207.


Development of an Extended-Specificity Multiplex Immunoassay for Detection of Streptococcus pneumoniae Serotype-Specific Antigen in Urine by Use of Human Monoclonal Antibodies.

Eletu S, Sheppard C, Thomas E, Smith K, Daniel P, Litt D Clin Vaccine Immunol. 2017; 24(12).

PMID: 28978509 PMC: 5717182. DOI: 10.1128/CVI.00262-17.


Burden of pneumococcal disease in adults aged 65 years and older: an Australian perspective.

Earle K, Williams S Pneumonia (Nathan). 2017; 8:9.

PMID: 28702288 PMC: 5471924. DOI: 10.1186/s41479-016-0008-8.


References
1.
Sheppard C, Harrison T, Smith M, George R . Development of a sensitive, multiplexed immunoassay using xMAP beads for detection of serotype-specific streptococcus pneumoniae antigen in urine samples. J Med Microbiol. 2010; 60(Pt 1):49-55. DOI: 10.1099/jmm.0.023150-0. View

2.
van Mens S, Meijvis S, Endeman H, van Velzen-Blad H, Biesma D, Grutters J . Longitudinal analysis of pneumococcal antibodies during community-acquired pneumonia reveals a much higher involvement of Streptococcus pneumoniae than estimated by conventional methods alone. Clin Vaccine Immunol. 2011; 18(5):796-801. PMC: 3122512. DOI: 10.1128/CVI.00007-11. View

3.
Elberse K, van de Pol I, Witteveen S, van der Heide H, Schot C, van Dijk A . Population structure of invasive Streptococcus pneumoniae in The Netherlands in the pre-vaccination era assessed by MLVA and capsular sequence typing. PLoS One. 2011; 6(5):e20390. PMC: 3102707. DOI: 10.1371/journal.pone.0020390. View

4.
Meijvis S, Hardeman H, Remmelts H, Heijligenberg R, Rijkers G, van Velzen-Blad H . Dexamethasone and length of hospital stay in patients with community-acquired pneumonia: a randomised, double-blind, placebo-controlled trial. Lancet. 2011; 377(9782):2023-30. DOI: 10.1016/S0140-6736(11)60607-7. View

5.
Marchese A, Esposito S, Coppo E, Rossi G, Tozzi A, Romano M . Detection of Streptococcus pneumoniae and identification of pneumococcal serotypes by real-time polymerase chain reaction using blood samples from Italian children ≤ 5 years of age with community-acquired pneumonia. Microb Drug Resist. 2011; 17(3):419-24. DOI: 10.1089/mdr.2011.0031. View